INDIVIOR PHARMACEUTICALS, INC.

Business Segments Indivior Pharmaceuticals, Inc.

Stocks

INDV

US45579U1097

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 21:00:00 15/06/2026 BST			5-day change	1st Jan Change
38.40 ^USD	-0.21%		+2.70%	+7.02%

06-10	Indivior Pharmaceuticals Insider Sold Shares Worth $1,357,200, According to a Recent SEC Filing	MT
05-20	Indivior Pharmaceuticals Announces Findings From Real-World Evidence Studies on Monthly Injectable Buprenorphine	CI

Sales 2025 by Business Segment

© MarketScreener.com See more

Sales 2025 by Geography

© MarketScreener.com See more

Historical Breakdown of Revenue by Business Segments

Net Income: Breakdown by Business Segment

Breakdown by Business Segment (USD)

Fiscal Period: December	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Pharmaceutical Products
Development, Manufacture and Sale of Buprenorphine-Based Prescription Drugs						791M	901M	1.09B	1.19B	1.24B
Total Assets						1.83B	1.77B	1.95B	1.32B	1.2B
Interest Expense						-18M	-22M	-30M	-41M	-45M
Income Tax Expense						-15M	-42M	-1M	11M	29M
CAPEX						-34M	-6M	-8M	-29M	-66M
EBT						190M	-95M	1M	14M	239M
Gross Profit						664M	742M	907M	957M	994M
D&A						19M	19M	18M	26M	20M
Operating Income						213M	-85M	-4M	32M	262M
Net Income						205M	-53M	2M	2M	210M

Geographical Revenue Distribution History

Geographical breakdown of sales (USD)

Fiscal Period: December	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
United States						603M	731M	912M	1.01B	1.05B
Total Assets						133M	65M	214M	-	-
Rest of World						181M	164M	176M	179M	186M
Total Assets						5M	3M	3M	-	-
United Kingdom						7M	6M	5M	-	-
Total Assets						145M	223M	206M	-	-

Stock Market
Stocks
INDV Stock
Financials Indivior Pharmaceuticals, Inc.
Business Segments

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrows Top Investments!

SEIZE THE OFFER!